drugset / Trial / NCT02019875
CYP3A4 Activity and Mineral Homeostasis
Phase 0
Completed
92 enrolled
University of Washington
National Institute of General Medical Sciences (NIGMS) · collab
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to determine whether changes in the activity of the enzyme CYP3A4 can change the Vitamin D and bone mineral homeostasis.
Timeline
- Start
- 2014-06
- Primary completion
- 2020-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clarithromycin | Small molecule | 250 mg | — |
| Comparator | Rifampin | Small molecule | 600 mg | — |